Healthcare / Biotech · Podcasts

Healthcare / Biotech podcasts worth following, and what each is good for

These are the podcasts Briefwire reads to cover Healthcare / Biotech, each one fetched and checked before it is listed. Where operators and investors reason out loud at length. The receipt for a line from one of these is a timestamp.

Start the 14-day trial Get three lines free on Monday

The list

In no ranked order. The note beside each says what it is good for, which is a different thing from how big it is.

Business of Biotech
Biotech-executive interviews on financing and manufacturing; ships episode transcripts.
A Health Podyssey
Health Affairs authors explaining their own study's policy consequences; ships transcripts, so the health-policy evidence layer is extractable.
Relentless Health Value
Stacey Richter pressing payer, employer and provider executives on where the money actually goes; transcripts published for 400 episodes.
Healthcare Unfiltered (Chadi Nabhan)
A practising oncologist interviewing pharma and oncology leaders with unusual candour on pricing and evidence; transcripts included.
Medsider
Medtech founders and CEOs on FDA pathways, reimbursement and raising capital; transcripts make 250 device-exec interviews searchable.
CareTalk
Two health-industry operators arguing about payer and provider strategy weekly, with named guests and transcripts.
The Readout Loud
STAT's weekly biotech show; reporters explain what a readout means commercially.
Raising Health
a16z Bio+Health's show on healthcare business models and reimbursement.
The Heart of Healthcare
Digital-health CEO interviews on payer contracts and go-to-market.
The Long Run
Luke Timmerman's biotech-leader interviews; deep on capital markets for drug developers.
Claims Denied (Hospitalogy)
Health-system finance show from the Hospitalogy team; payer-provider economics.
Ground Truths (Eric Topol)
A clinical analyst on evidence quality in medical AI; the counterweight to vendor claims.
Lifers (Christina Farr)
A former CNBC health-tech reporter turned investor interviewing digital-health operators; strong on why companies actually failed.
Biotech 2050
Biotech CEO and founder interviews on platform strategy and financing; complements the Long Run's capital-markets angle already held.
Tradeoffs
Health-policy reporting built on interviews with the researchers and administrators making coverage decisions; rigorous on Medicaid.

How the list was made, and what we do with it

Chosen by hand: Every source is here because people who work in Healthcare / Biotech say substantive things on it, not because it is large. Enough of them to cover the field, few enough to audit.
Checked before listing: Each feed is fetched before it goes on the list, and a feed that answers but has stopped publishing is a fail, not a warning. Every source is English-language and public.
Read, so you need not: You do not have to listen to all of them. Each new episode is read from its published transcript, or transcribed when there is none, and the claims worth keeping are pulled out with the timestamp where each was said.
Sent as a brief: The 12 lines that rank highest across the whole Healthcare / Biotech beat go out daily or weekly. A claim several independent sources made ranks higher — that counts agreement, not accuracy.

The podcasts are one part of the beat. Every Healthcare / Biotech source, all media — or just the blogs and newsletters or changelogs and release feeds.

Run one of these, or think one is missing? How sources are attributed, and how to reach us.

Podcasts in other industries

Healthcare / Biotech in 12 lines a brief, each with a receipt.

14 days of Desk, every seat, card on file — cancel before day 14 and it is never charged. Or take three lines free by email every Monday, no account.

Start the 14-day trial Get three lines free on Monday